A detailed history of Coppell Advisory Solutions LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 1,134 shares of CORT stock, worth $59,160. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,134
Previous 4 28250.0%
Holding current value
$59,160
Previous $130,000 38220.77%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$29.51 - $46.26 $33,346 - $52,273
1,130 Added 28250.0%
1,134 $49.8 Million
Q2 2024

Aug 15, 2024

SELL
$22.21 - $34.48 $621 - $965
-28 Reduced 87.5%
4 $130,000
Q4 2023

Feb 14, 2024

BUY
$24.82 - $32.88 $794 - $1,052
32 New
32 $1.04 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.59B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.